Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2CUREX.ST Stock Summary
Top 10 Correlated ETFs
2CUREX.ST
In the News
2CUREX.ST Financial details
Company Rating
Neutral
Market Cap
8.41M
Income
-29.95M
Revenue
167K
Book val./share
0.78
Cash/share
0.76
Dividend
-
Dividend %
-
Employees
14
Optionable
No
Shortable
Yes
Earnings
22 Feb 2024
P/E
-0.97
Forward P/E
-
PEG
-1.08
P/S
134.32
P/B
1.88
P/C
0.47
P/FCF
-1.12
Quick Ratio
4.84
Current Ratio
5.53
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.7
EPS next Y
-
EPS next Q
-
EPS this Y
12.18%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
20.81%
Revenue last 5Y
-58.09%
Revenue Q/Q
-
EPS Q/Q
-51.72%
-
-
-
-
SMA20
-69.57%
SMA50
-77.1%
SMA100
-81.44%
Inst Own
-
Inst Trans
-
ROA
-161%
ROE
-112%
ROC
-1.89%
Gross Margin
100%
Oper. Margin
-13441%
Profit Margin
-13865%
Payout
-
Shs Outstand
17.6M
Shs Float
10.91M
-
-
-
-
Target Price
-
52W Range
0.286-7.78
52W High
-
52W Low
-
RSI
18.29
Rel Volume
0.1
Avg Volume
73.8K
Volume
7.59K
Perf Week
-47.16%
Perf Month
-80.33%
Perf Quarter
-88.16%
Perf Half Y
-89.27%
-
-
-
-
Beta
0.797
-
-
Volatility
0.08%, 0.52%
Prev Close
-7.81%
Price
0.354
Change
6.95%
2CUREX.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.03 | 1.13 | 0.45 | 0.01 | 0.01 | |
Net income per share | -0.68 | -0.54 | -1.15 | -1.56 | -1.75 | |
Operating cash flow per share | -0.68 | -0.86 | -1.12 | -1.59 | -1.84 | |
Free cash flow per share | -0.68 | -0.89 | -1.12 | -1.62 | -1.84 | |
Cash per share | 2.9 | 4.31 | 4.44 | 2.55 | 0.76 | |
Book value per share | 2.42 | 4.33 | 4.53 | 2.45 | 0.78 | |
Tangible book value per share | 2.42 | 4.33 | 4.53 | 2.45 | 0.78 | |
Share holders equity per share | 2.42 | 4.33 | 4.53 | 2.45 | 0.78 | |
Interest debt per share | 0.06 | 0.02 | 0.01 | -0.13 | 0 | |
Market cap | 158.46M | 225.16M | 275.84M | 143.28M | 35.38M | |
Enterprise value | 124.74M | 166.58M | 202.89M | 98.39M | 21.98M | |
P/E ratio | -19.98 | -30.76 | -14.57 | -5.23 | -1.15 | |
Price to sales ratio | 13.23 | 14.63 | 37.32 | 1.59K | 228.27 | |
POCF ratio | -20.15 | -19.25 | -14.97 | -5.12 | -1.09 | |
PFCF ratio | -20 | -18.61 | -14.94 | -5.02 | -1.09 | |
P/B Ratio | 5.64 | 3.83 | 3.71 | 3.33 | 2.58 | |
PTB ratio | 5.64 | 3.83 | 3.71 | 3.33 | 2.58 | |
EV to sales | 10.41 | 10.82 | 27.45 | 1.09K | 141.8 | |
Enterprise value over EBITDA | -15.01 | -20.91 | -9.21 | -3.34 | -0.59 | |
EV to operating cash flow | -15.86 | -14.25 | -11.01 | -3.52 | -0.68 | |
EV to free cash flow | -15.74 | -13.77 | -10.99 | -3.45 | -0.68 | |
Earnings yield | -0.05 | -0.03 | -0.07 | -0.19 | -0.87 | |
Free cash flow yield | -0.05 | -0.05 | -0.07 | -0.2 | -0.92 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 4.06 | 7.35 | 3.31 | 1.52 | 0.36 | |
Current ratio | 3.77 | 14.84 | 16.29 | 10.09 | 5.42 | |
Interest coverage | -13.22 | -30.91 | -219.24 | 13.6 | 0 | |
Income quality | 0.9 | 1.58 | 0.81 | 0.87 | 1.05 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.78 | 0.65 | 1.61 | 137.6 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.01 | 0.03 | 0 | 0.02 | 0 | |
Capex to revenue | 0 | -0.03 | 0 | -6.01 | 0 | |
Capex to depreciation | -0.14 | -1.04 | -0.09 | -1.74 | 0 | |
Stock based compensation to revenue | 0.03 | 0.03 | 0.27 | 13.51 | 0 | |
Graham number | 6.1 | 7.24 | 10.84 | 9.27 | 5.54 | |
ROIC | -0.26 | -0.11 | -0.26 | -0.69 | -2.38 | |
Return on tangible assets | -0.21 | -0.12 | -0.24 | -0.58 | -1.85 | |
Graham Net | 2.25 | 4.13 | 4.38 | 2.34 | 0.7 | |
Working capital | 27.06M | 57.87M | 73.65M | 42.04M | 12.99M | |
Tangible asset value | 28.08M | 58.86M | 74.34M | 43.03M | 13.69M | |
Net current asset value | 27.06M | 57.87M | 73.65M | 42.04M | 12.99M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 1.41M | 2.58M | 3.66M | 3.09M | 1.86M | |
Average payables | 1.06M | 1.28M | 1.72M | 2.05M | 814.5K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 85.87 | 55.35 | 245.93 | 4.83K | 5.93K | |
Days payables outstanding | 1.34K | 914.39 | 2.56K | 16.75 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 4.25 | 6.59 | 1.48 | 0.08 | 0.06 | |
Payables turnover | 0.27 | 0.4 | 0.14 | 21.79 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.28 | -0.12 | -0.25 | -0.64 | -2.25 | |
Capex per share | -0.01 | -0.03 | 0 | -0.03 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.54 | -0.38 | -0.46 | -0.58 | -0.28 | |
Operating cash flow per share | -0.17 | -0.58 | -0.51 | -0.44 | -0.31 | |
Free cash flow per share | -0.2 | -0.58 | -0.51 | -0.44 | -0.31 | |
Cash per share | 2.55 | 1.98 | 1.49 | 1.03 | 0.76 | |
Book value per share | 2.45 | 2.03 | 1.55 | 1.01 | 0.78 | |
Tangible book value per share | 2.45 | 2.03 | 1.55 | 1.01 | 0.78 | |
Share holders equity per share | 2.45 | 2.03 | 1.55 | 1.01 | 0.78 | |
Interest debt per share | 0 | -0.05 | 0 | 0 | 0 | |
Market cap | 143.28M | 113.19M | 72.35M | 57.03M | 35.38M | |
Enterprise value | 98.39M | 78.36M | 46.05M | 38.93M | 21.98M | |
P/E ratio | -3.77 | -4.22 | -2.22 | -1.4 | -1.8 | |
Price to sales ratio | 1.75K | 8.71K | 1.08K | 655.56 | 0 | |
POCF ratio | -49.27 | -10.99 | -8.13 | -7.38 | -6.4 | |
PFCF ratio | -41.54 | -10.99 | -8.13 | -7.38 | -6.4 | |
P/B Ratio | 3.33 | 3.17 | 2.64 | 3.21 | 2.58 | |
PTB ratio | 3.33 | 3.17 | 2.64 | 3.21 | 2.58 | |
EV to sales | 1.2K | 6.03K | 687.39 | 447.46 | 0 | |
Enterprise value over EBITDA | -21.18 | -9.36 | -5.37 | -4.25 | -2.48 | |
EV to operating cash flow | -33.83 | -7.61 | -5.18 | -5.04 | -3.98 | |
EV to free cash flow | -28.53 | -7.61 | -5.18 | -5.04 | -3.98 | |
Earnings yield | -0.07 | -0.06 | -0.11 | -0.18 | -0.14 | |
Free cash flow yield | -0.02 | -0.09 | -0.12 | -0.14 | -0.16 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 9.66 | 4.16 | 3.06 | 1.97 | 1.51 | |
Current ratio | 10.09 | 12.96 | 12.02 | 5.53 | 5.42 | |
Interest coverage | -308.43 | 9.69 | 0 | 0 | 0 | |
Income quality | 0.31 | 1.54 | 1.09 | 0.76 | 1.12 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 32.48 | 212.08 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.19 | 0 | 0 | 0 | 0 | |
Capex to revenue | -6.6 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -6.36 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 14.83 | 0 | 0 | 0 | 0 | |
Graham number | 5.46 | 4.17 | 4.03 | 3.62 | 2.21 | |
ROIC | -0.22 | -0.21 | -0.32 | -0.52 | -0.34 | |
Return on tangible assets | -0.2 | -0.17 | -0.27 | -0.47 | -0.3 | |
Graham Net | 2.34 | 1.93 | 1.47 | 0.93 | 0.7 | |
Working capital | 42.04M | 34.74M | 26.49M | 16.96M | 12.99M | |
Tangible asset value | 43.03M | 35.68M | 27.36M | 17.74M | 13.69M | |
Net current asset value | 42.04M | 34.74M | 26.49M | 16.96M | 12.99M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 3.41M | 2M | 2.7M | 2.59M | 2.56M | |
Average payables | 814.5K | 814.5K | 0 | 0 | 0 | |
Average inventory | -2.82M | 0 | 0 | 0 | 0 | |
Days sales outstanding | 1.31K | 19.45K | 3.49K | 2.68K | 0 | |
Days payables outstanding | 16.01 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.07 | 0 | 0.03 | 0.03 | 0 | |
Payables turnover | 5.62 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 2511750.56B | 0 | 0 | |
ROE | -0.22 | -0.19 | -0.3 | -0.57 | -0.36 | |
Capex per share | -0.03 | 0 | 0 | 0 | 0 |
2CUREX.ST Frequently Asked Questions
What is 2cureX AB (publ) stock symbol ?
2cureX AB (publ) is a DK stock and trading under the symbol 2CUREX.ST
What is 2cureX AB (publ) stock quote today ?
2cureX AB (publ) stock price is $0.354 today.
Is 2cureX AB (publ) stock public?
Yes, 2cureX AB (publ) is a publicly traded company.